Delivery Order SPE2DB22D2009-SPE2DB25FL7KU

Award Date 1/21/25
Potential Completion Date 1/22/25
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,445.16 firm fixed-price delivery order is for CHLORASEPTIC MAX 15-10 MG LOZ 15S, a medical product. The contract has an ultimate completion date of March 21, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $2,943.31, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CHLORASEPTIC MAX 15-10 MG LOZ 15S, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award is a delivery order with a firm fixed price valued at $1,457.47, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4566405605 - CHLORASEPTIC MAX 15-10 MG LOZ 15S, with a period of performance through November 13, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal delivery order contract valued at $4,865.62, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract provides CHLORASEPTIC MAX 15-10 MG LOZ 15S, a medical product, with an ultimate completion date of October 16, 2023. The contract is a firm fixed-price, with no set-aside designation. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Chloraseptic Max 15-10 mg lozenge products. The contract has a ceiling value of $1,076.82 and a period of performance through March 11, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the procurement of CHLORASEPTIC MAX 15-10 MG LOZ 15S. The $13,759.31 firm fixed price delivery order does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, valued at $3,503.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of Chloraseptic Max 15-10 mg lozenges to support military healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle for Amerisourcebergen to provide a comprehensive...
This federal contract award is for the delivery of CHLORASEPTIC MAX 15-10 MG LOZ 15S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a total ceiling value of $3,706.92 and an ultimate completion date of December 24, 2024. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition....
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,461.01 firm fixed-price delivery order is for the supply of Chloraseptic Max 15-10 mg Lozenges. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,338.94, is for the procurement of Chloraseptic Max 15-10 mg lozenges. The contract is a firm fixed-price delivery order, with a period of performance through January 8, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB25FL7KU
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,604.52 firm fixed-price delivery order is for the supply of CHLORASEPTIC MAX 15-10 MG LOZ 15S, a pharmaceutical product. The contract has an ultimate completion date of January 22, 2025.

AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is likely a task order issued under that larger IDC mechanism. The contract award does not mention any set-aside designations, indicating open competition.

Generated 4/22/25, 11:47 AM